Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Atrial Fibrillation (AF)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • SEC Clinical Research, Dothan, Alabama, United States

  • Mission Cardiovascular Research Institute, Fremont, California, United States

  • National Institute of California Heart and Vein Specialists, Huntington Beach, California, United States

  • Profound Research LLC at Southern California Heart Specialists, Pasadena, California, United States

  • Cardiology Associates Medical Group, Ventura, California, United States

  • Interventional Cardiology Medical Group, West Hills, California, United States

  • South Florida Research Organization LLC, Medley, Florida, United States

  • Sec Clinical Research, Pensacola, Florida, United States

  • Clinical Site Partners, LLC DBA Flourish Research, Winter Park, Florida, United States

  • NSC Research, Inc, Johns Creek, Georgia, United States

  • Monroe Research, LLC, West Monroe, Louisiana, United States

  • Profound Research, Millennium Cardiology, Farmington Hills, Michigan, United States

  • AA Medical Research Center (MRC), Flint, Michigan, United States

  • K&R Research LLC, Marion, Ohio, United States

  • AnMed Health, Anderson, South Carolina, United States

  • PharmaTex Research, Amarillo, Texas, United States

  • Southwest Family Medicine Associates, Dallas, Texas, United States

  • Texas Institute of Cardiology PA, McKinney, Texas, United States

מובילי המחקר
  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals